Squarepoint’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,676
Closed -$181K – 4440
2025
Q1
$181K Sell
1,676
-1,752
-51% -$152K ﹤0.01% 4049
2024
Q4
$163K Buy
+3,428
New +$207K ﹤0.01% 4549
2024
Q1
– Sell
-1,200
Closed -$377K – 3958
2023
Q4
$377K Buy
+1,200
New +$434K ﹤0.01% 3211

Other funds holding AGL

Squarepoint's AGL Position: Q2 2026 in Review

Squarepoint opened a new position in Agilon Health (AGL) in Q2 2026: 3,796 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #3581 among its holdings. This is a return to the name: Squarepoint previously reported a position in AGL as recently as Q3 2025.

Squarepoint first reported a position in AGL in Q4 2022 and has held it in 9 quarters since. The position peaked at $2.54M in Q4 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Squarepoint held 3,796 shares of Agilon Health worth $407K as of Q2 2026.
  • Agilon Health was a new Squarepoint position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3581 holding.
  • Squarepoint first reported a position in Agilon Health in Q4 2022 and has held it in 9 quarters since.
  • Squarepoint's Agilon Health position peaked at $2.54M in Q4 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.